Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: Role of extracellular signal-regulated kinases

Journal of Hypertension

Volumn 17, Issue 7, 1999, Pages 907-916

  Touyz, Rhian M ^a   Deng, Li Yuan ^b   He, Gang ^b   Wu, Xiao Hua ^b   Schiffrin, Ernesto L ^b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b NONE

Author keywords

Angiotensin receptors; Aorta; MAP kinases; Proliferation; Resistance arteries; Signal transduction

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ENDOTHELIN 1; LOSARTAN; PHOSPHOTRANSFERASE;

AORTA; ARTERY; ARTICLE; CELL GROWTH; CELL HYPERPLASIA; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033024798     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917070-00006     Document Type: Article

References (54)

1. 1 Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension 1992; 20:713-736.
2. 2 Pratt RE. Regulation of vascular smooth-muscle cell growth by angiotensin II. Blood Pressure 1996; 2:6-9.
3. 3 Sauro MD, Sudakow R, Burns S. In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine kinase-dependent mechanism. J Pharmacol Exp Ther 1996; 277:1744-1750.
4. 4 Timmermans PMWM, Penfield P, Chin AT, Horbln WF, Wong PC, Smith RD. Angiotensin II receptors and functional correlates. Am J Hypertens 1992; 5:2215-2355.
5. 5 Matsubara H. Pathophysiological rote of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circul Res 1998; 83:1182-1191.
6. 6 Tzuzuki S, Matoba T, Eguchi S, Inagami T. Angiotensin II type 2 receptor inhibits cell proliferation and activates lyrosine phosphatase. Hypertension 1996; 28:916-918.
7. 7 Griendling KK, Ushio-Fukai M, Lassègue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997; 20:366-373.
8. 8 Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Role of tyrosine kinases. Circul Res 1997; 80:607-616.
9. 9 Touyz RM, Schiffrin EL. Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium transients in vascular smooth muscle cells. Hypertension 1996; 27:1097-1103.
10. 10 Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998; 31:152-161.
11. 11 Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G-protein-coupled receptors. Cell Signal 1997; 9:337-351.
12. 12 Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells. Circul Res 1988; 62:749-756.
13. 13 Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured smooth muscle cells. Hypertension 1989; 13:305-314.
14. 14 Sachinidis A, Ko Y, Nettekoven W, Eieczorek AJ, Dusing R, Vetter H. The effects of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar-Kyoto rats. J Hypertens 1992; 10:1159-1164.
15. 15 Gibbons GH, Pratt RE, Dzau V. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90:456-461.
16. 1 receptor. J Hypertens 1992; 10:1436-1469.
17. + exchange and stimulates growth in cultured vascular smooth muscle cells. J Hypertens 1988; 6 (suppl 4):S438-S441.
18. 18 Patel MK, Betteridge U, Hughes AD, Clunn DG, Schachter M, Shaw RJ, et al. Effect of angiotonsin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J Hypertens 1996; 14:341-347.
19. 2 on the production of matrix metalloproteinase by human aortic smooth muscle cells. Biochem Mol Biol Int 1995; 35:265-273.
20. 20 Hatakeyama H, Miyamori I, Yamagishi S, Takeda Y, Takeda R, Yamamoto H. Angiotensin II upregulates the expression of type A endothelin receptor in human vascular smooth muscle cells. Biochem Mol Biol Int 1994; 34:127-134.
21. 21 Yazawa H, Iida-Kubota E, Honda K. Human aortic smooth muscle cells containing angiotensin II type I receptors. Jpn J Pharmacol 1993; 62:339-343.
22. 22 Makita S, Nakamura M, Yoshida H, Hiramori K. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells. Life Sci 1995; 56:383-388.
23. 23 Kruse HJ, Bauriedel G, Heimerl J, Hofling B, Weber PC. Role of L-type calcium channels on stimulated calcium influx and on proliferative activity of human coronary smooth muscle cells. J Cardiovasc Pharmacol 1994; 24:328-335.
24. 24 Svane D, Kahr O, Hansen VB, Holm-Nielsen P, Formar A, Angiotensin-convertin enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries. Am J Obstet Gyn 1995; 172:991-997.
25. 25 Frohlich ED, Tarazi RC, Dustan HP. Re-examination of the hemodynamics of hypertension. Am J Med Sci 1969; 257:9-23.
26. 26 Safar ME, London GM, Asmar R, Frohlich ED. Recent advances on large arteries in hypertension. Hypertension 1998; 32:156-161.
27. 27 Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91.
28. 28 Touyz RM, Tolloczco B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II, but not to endothelin-1. Hypertension 1994; 12:663-673.
29. 29 Touyz RM, Schiffrin EL. Angiotensin II regulates vascular smooth muscle cell pH, contraction and growth via tyrosine-kinase dependent signaling pathways. Hypertension 1997; 30:222-229.
30. 30 Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995; 92:7686-7689.
31. 31 Bateman A, Singh A, Congote LF, Solomon S. The effect of HP-1 and related neutrophoil granule peptides on DNA synthesis in HL60 cells. Reg Peptides 1991; 3592:135-143.
32. 32 Buttenburg B, van Amelsvoort T, Rogg H, Wood JM. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 1992; 20:746-754.
33. 33 Griffin SA, Brown WCB, Macpherson F, McGrath JC, Wilson VG, Korsgaard N, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17:626-635.
34. 34 Servant MJ, Giasson E, Meloche S. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibtor in aortic smooth muscle cells. J Biol Chem 1996; 271:16047-16052.
35. 35 Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, et al. Endothelin-1 and angiotensin II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol 1994; 8:148-158.
36. 36 Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circul Res 1991; 68:450-456.
37. 37 Scott-Burden T, Resink TJ, Hahn AWA, Buhler FR. Angiotensin-induced growth related metabolism is activated in cultured smooth muscle cells from spontaneously hypertensive rats and Wistar-Kyoto rats. Am J Hypertens 1991;4:183-188.
38. 38 Virone-Oddos A, Desangle V, Provost D, Cazes M, Caussade F, Cloarec A. In vitro and in vivo effects of UP269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Br J Pharmacol 1997; 120:488-494.
39. 39 Peiro C, Rodriquez-Lopez AM, Angulo J, Regadera J, Marin J, Sanchez-Forrer CF. et al. Endogenous angiotensin II and cell hypertrophy in vascular smooth muscle cultures from hypertensive Ren-2 transgenic rats. Cell Physiol Biochem 1998; 8:106-116.
40. 40 Dominiczak AF, Devlin AM, Lee WK, Anderson NH, Bohr DF, Reid JL. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension. Hypertension 1996; 27:752-759.
41. 41 Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau V. Multilple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91:2268-2274.
42. 42 Mii S, Ware JA, Mallette SA, Kent KC. Effect of angiotensin II on human vascular smooth muscle cell growth. J Surg Res 1994; 57:170-178.
43. 43 Assender JW, Irenius E, Fredholm BB. 5-Hydroxytryptamine, angiotensin and bradykinin transiently increase intracellular calcium concentrations and PKC-alpha activity, but do not induce mitogenesis in human vascular smooth muscle cells. Acta Phys Scand 1997; 160:207-217.
44. 44 Campbell-Boswell M, Robertson AL Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1984; 35:265-276.
45. 2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension 1998; 31:487-492.
46. 1 angiotensin-receptor blockade on structure and function of small arteries in SHR. J Cardiovasc Pharmacol 1997; 30:75-83.
47. 47 Schiffrin EL, Deng LY, Larouchelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91.
48. 48 Schramek H, Sorokin A, Watson RD, Dunn MJ. ET-1 and PDGF BB induce MEK mRNA and protein expression in mesangial cells. J Cardiovasc Pharmacol 1995; 26 (suppl 3):S95-S99.
49. B receptors promote proliferation and migration of endothelial cells, J Cardiovasc Pharmacol 1995; 26 (suppl 3):S284-S286.
50. A receptor-mediated phenomenon. Br J Pharmacol 1996; 118:191-197.
51. 51 Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 1995; 25:1135-1143.
52. 52 Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Role of tyrosine kinases. Circul Res 1997; 80:607-616.
53. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998; 32:488-496.
54. 54 Seewald S, Seul C, Kettenhofen R, Bokemeyer D, Ko Y, Vetter H, et al. Role of mitogen-activated protein kinase in the angiotensin II-induced synthesis in vascular smooth muscle cells. Hypertension 1998; 31:1151-1156.